Parkview Health Logo

Sarcoma & Musculoskeletal Tumor Care Team

Cancer Care Teams

Orthopedic oncology

Parkview Packnett Family Cancer Institute is home to the region’s only team of experts dedicated to the treatment of patients with sarcoma and musculoskeletal tumors. Sarcomas are rare and potentially aggressive cancers that arise from connective tissue – muscle, fat, nerves and bones. Our multidisciplinary team approach provides patient-focused, world-class care utilizing contemporary techniques and advanced technologies for individuals with sarcoma and musculoskeletal tumors. Now you can be treated at a specialized sarcoma center, close to home.

Call 833-724-8326 for information on scheduling an appointment. 

Conditions we treat

The Parkview Packnett Family Cancer Institute orthopedic oncology team consists of experts in the treatment of complex orthopedic conditions including, but not limited to:

Second opinions

You can get a second opinion from Parkview Packnett Family Cancer Institute at any stage in your cancer journey. 

Learn more

Our state-of-the-art Parkview Packnett Family Cancer Institute


Meet Our Team

Sarcoma care requires a subspecialized and experienced multidisciplinary team. Many studies have demonstrated that patient outcomes are significantly improved when treated at a center with a dedicated sarcoma team.

Our Sarcoma Care Team consists of multi-disciplinary specialists, including:

  • Orthopedic oncologist
  • Sarcoma medical oncologist
  • Sarcoma radiation oncologist
  • Pathologists
  • Musculoskeletal radiologist
  • Interventional radiologists
  • Microvascular plastic surgeons
  • Vascular surgeons
  • Spine surgeons
  • General surgeons
  • Colorectal surgeons
  • Urologists
  • Gynecology oncologists
  • Anesthesiologists
  • Advanced practitioners
  • Genetic counselors
  • Nurse navigators
  • High-risk clinic
  • Survivorship clinic
  • Palliative oncologists
  • Prosthetic team
  • Physical and occupational therapists
  • Financial counselors
  • Social workers
  • Chaplains
  • Research team

Christopher Johnson, DO